tiprankstipranks
Advertisement
Advertisement
Enveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year
PremiumThe FlyEnveric Biosciences reports Q1 EPS ($1.08) vs. ($14.58) last year
20d ago
Enveric Biosciences sees cash runway into 1Q27
Premium
The Fly
Enveric Biosciences sees cash runway into 1Q27
20d ago
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
Premium
The Fly
Psychedelic: Compass Pathways, AtaiBeckley, GH Research report earnings
20d ago
Enveric Biosciences trading resumes
PremiumThe FlyEnveric Biosciences trading resumes
1M ago
Enveric Biosciences trading halted, volatility trading pause
Premium
The Fly
Enveric Biosciences trading halted, volatility trading pause
1M ago
Enveric Biosciences files to sell 6.82M shares of common stock
Premium
The Fly
Enveric Biosciences files to sell 6.82M shares of common stock
1M ago
Enveric Biosciences secures new U.S. patent for its EVM301 series
PremiumThe FlyEnveric Biosciences secures new U.S. patent for its EVM301 series
2M ago
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
Premium
The Fly
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
3M ago
Enveric Biosciences announces registration of five trademarks in Canada
Premium
The Fly
Enveric Biosciences announces registration of five trademarks in Canada
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100